In this episode, the Executive Chair of the 2026 ISPE Annual Meeting and Expo, Jose Caraballo Oramas, and the International Program Committee Chair, Connie Langer, join the podcast to preview the upcoming conference in Washington, D.C. They explore the featured topics, trends, and key highlights of what attendees can expect from the educational content and agenda.

Learn about the interconnected educational tracks, which delve into topics like how pharmaceutical operations can balance advanced digital innovations, such as artificial intelligence, with robust governance and human accountability, and how modern systems and workforce upskilling contribute to reliable, patient-centric drug manufacturing.

In this episode, the Executive Chair of the 2026 ISPE Annual Meeting and Expo, Jose Caraballo Oramas, and the International Program Committee Chair, Connie Langer, join the podcast to preview the upcoming conference in Washington, D.C. They explore the featured topics, trends, and key highlights of what attendees can expect from the educational content and agenda.

Learn about the interconnected educational tracks, which delve into topics like how pharmaceutical operations can balance advanced digital innovations, such as artificial intelligence, with robust governance and human accountability, and how modern systems and workforce upskilling contribute to reliable, patient-centric drug manufacturing.

n this episode, listen to highlights from our most recent Artificial Intelligence-focused episodes, featuring discussions with speakers from the FDA, Sanofi, and the Open BioPharma Research and Training Institute on the potential for AI to reshape the drug lifecycle, how companies are leveraging artificial intelligence to drive quality transformation and accelerate workforce readiness, and more.

n this episode, listen to highlights from our most recent Artificial Intelligence-focused episodes, featuring discussions with speakers from the FDA, Sanofi, and the Open BioPharma Research and Training Institute on the potential for AI to reshape the drug lifecycle, how companies are leveraging artificial intelligence to drive quality transformation and accelerate workforce readiness, and more.

In this recap episode, Michelle Vuolo, Head of Quality at Tulip Interfaces and ISPE Good Practice Guide: Validation 4.0 co-lead, along with guide team member, Victor de Oliveira Silva Ferreira, Cruz, Project Manager for PEQMS – Implementation of Electronic Systems for the Quality Management System, Instituto De Tecnologia Em Imunobiológico/Fundação Oswaldo Cruz, join the podcast share their insights on how Validation 4.0 aims to leverage digital tools to transition from traditional validation methods to more dynamic, real-time processes.

In this recap episode, Michelle Vuolo, Head of Quality at Tulip Interfaces and ISPE Good Practice Guide: Validation 4.0 co-lead, along with guide team member, Victor de Oliveira Silva Ferreira, Cruz, Project Manager for PEQMS – Implementation of Electronic Systems for the Quality Management System, Instituto De Tecnologia Em Imunobiológico/Fundação Oswaldo Cruz, join the podcast share their insights on how Validation 4.0 aims to leverage digital tools to transition from traditional validation methods to more dynamic, real-time processes.

In this episode, Miguelina Matthews, Head of Quality Intelligence, Advocacy and Pharmacopoeia Affairs at Sanofi, joins the podcast to share how the company is leveraging artificial intelligence to shift pharmaceutical quality management from reactive investigations to predictive, data-driven insights. Learn more about the deployment of Sanofi's "Plai" tool, emphasizing the importance of robust governance, effective change management, and human-led decision-making in scaling AI technologies across global operations.

In this episode, Miguelina Matthews, Head of Quality Intelligence, Advocacy and Pharmacopoeia Affairs at Sanofi, joins the podcast to share how the company is leveraging artificial intelligence to shift pharmaceutical quality management from reactive investigations to predictive, data-driven insights. Learn more about the deployment of Sanofi's "Plai" tool, emphasizing the importance of robust governance, effective change management, and human-led decision-making in scaling AI technologies across global operations.

On this episode, David Estapé, Technology Manager Biotechnology at CRB Group GmbH, and International Program Committee Chair of the 2026 ISPE Europe Annual Conference, joins the podcast to discuss the upcoming conference and the topics, speakers, and key highlights of what you can expect from the educational content and agenda.

On this episode, David Estapé, Technology Manager Biotechnology at CRB Group GmbH, and International Program Committee Chair of the 2026 ISPE Europe Annual Conference, joins the podcast to discuss the upcoming conference and the topics, speakers, and key highlights of what you can expect from the educational content and agenda.